	R 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	C 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Total Revenue	522	617	864	893	906	994	1,073	1,192	1,363	1,420	1,504	1,801	1,966	2,000	2,140
Cost of Operating Revenue	360	427	624	684	709	778	802	869	1,066	1,124	1,176	1,460	1,553	1,454	1,558
Gross Profit	161	189	240	209	197	216	271	323	297	296	328	341	413	546	582
Gross Margin	30.9	30.7	27.8	23.4	21.7	21.7	25.3	27.1	21.8	20.8	21.8	18.9	21.0	27.3	27.2
Total Operating Expenses	468	554	789	797	830	896	941	1,020	1,226	1,292	1,359	1,705	1,833	1,805	1,937
Operating Profit	54	62	75	97	76	98	133	172	137	128	145	96	133	195	203
Operating Margin	10.4	10.1	8.7	10.8	8.4	9.9	12.3	14.4	10.1	9.0	9.6	5.3	6.8	9.8	9.5
Financing Income/(Expense) - Net	-11	-17	-26	-33	-25	-14	-17	-19	-27	0	-4	-13	-6	-1	-28
Profit before Taxes	43	46	49	64	50	82	118	153	111	120	141	84	132	193	187
Income Taxes	10	11	9	9	11	23	34	31	24	26	34	21	30	51	47
Profit after Tax	33	35	40	55	40	60	84	123	87	94	107	63	102	142	139
PAT Margin	6.3	5.7	4.6	6.1	4.4	6.0	7.9	10.3	6.4	6.6	7.1	3.5	5.2	7.1	6.5
EPS - Basic - ex Extraordinary Items	11.57	12.38	14.00	19.22	12.77	19.26	27.19	39.62	28.04	30.29	36.11	21.36	34.49	48.38	47.91
EPS - Diluted - ex Extraordinary Items	11.57	12.38	14.00	19.22	12.77	19.26	27.19	39.62	28.04	30.29	36.11	21.36	34.49	48.38	47.91
EBIT	54	62	75	97	76	98	133	172	137	128	145	96	133	195	203
EBITDA	57	68	82	111	92	114	150	191	161	153	171	122	163	224	239
EBITDA Margin	11.0	11.1	9.5	12.5	10.2	11.5	13.9	16.1	11.8	10.8	11.4	6.8	8.3	11.2	11.2

Balance Sheet

Abridged

Understanding Balance Sheet

Insecticides (India) Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	C 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	349	437	545	662	629	715	719	1,062	978	1,086	1,003	1,232	1,252	1,425	1,448
Long-Term Investments	-	-	11	3	3	3	8	4	2	4	5	7	13	12	17
Property Plant & Equipment - Net	123	181	220	245	242	238	241	250	267	286	333	372	411	426	477
Total Non-Current Assets	172	196	246	259	266	263	281	293	316	340	393	464	467	473	552
Total Assets	520	632	791	920	895	978	1,000	1,356	1,294	1,426	1,396	1,696	1,719	1,898	2,000
Total Current Liabilities	294	374	497	556	458	489	425	674	539	585	508	760	664	778	740
Long Term Debt	38	30	30	54	29	15	8	1	4	5	4	4	31	26	28
Total Non-Current Liabilities	44	46	48	74	33	25	28	20	23	21	19	19	44	36	39
Total Liabilities	338	420	545	630	490	514	452	694	563	606	527	778	708	814	780
Total Shareholders' Equity	182	212	247	291	405	464	548	662	732	820	870	918	1,012	1,085	1,220
Total Equity	182	212	247	291	405	464	548	662	732	820	870	918	1,012	1,085	1,220
Total Liabilities & Equity	520	632	791	920	895	978	1,000	1,356	1,294	1,426	1,396	1,696	1,719	1,898	2,000

Cash Flow

Abridged

Understanding Cash Flow Statement

Insecticides (India) Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	R 2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	37.25	40.40	47.11	71.56	53.51	82.48	107.74	144.95	103.19	117.69	130.72	77.77	147.07	187.00	164.19
Working Capital - Increase/(Decrease)	-84.22	-53.39	-25.10	-100.55	12.23	-98.92	58.21	-292.01	115.09	33.70	-2.01	-101.32	29.68	-97.95	-80.14
Net CF from Operating Activities	-46.97	-12.99	22.01	-28.98	65.74	-16.44	165.95	-147.05	218.28	151.39	128.71	-23.55	176.75	89.05	84.04
Capital Expenditures - Net	55.09	46.66	45.87	34.84	19.10	13.90	28.02	37.44	28.43	47.63	66.91	86.73	43.68	34.67	92.56
Net CF from Investing Activities	-55.09	-46.66	-56.96	-34.84	-19.10	-13.92	-26.22	-49.48	-25.23	-115.39	8.73	-86.64	-47.20	-40.30	-87.08
Dividends Paid - Cash - Total	3.17	3.17	3.80	3.80	9.30	-	4.98	4.98	14.95	4.13	-	14.80	8.88	5.92	5.82
Stock - Issuance/(Retirement) - Net	-	-	-	-	80.82	-	-	-	-	-	-59.19	-	-	-61.88	-
Debt - LT & ST - Issuance/(Retirement) - Total	119.75	50.28	43.74	64.51	-112.77	30.09	-122.04	190.90	-119.31	-93.14	-48.72	107.69	-78.21	13.69	40.15
Net Cash Flow from Financing Activities	116.07	46.59	39.29	60.06	-43.14	30.09	-127.02	185.92	-134.26	-97.27	-107.91	92.83	-87.09	-54.11	34.33
Free Cash Flow to Equity	17.69	-9.37	19.88	0.69	-66.13	-0.24	15.89	6.40	70.54	10.63	13.08	-2.59	54.86	68.07	31.64
Free Operating CF net dividend	-105.78	-65.91	-27.99	-67.97	36.76	-30.84	132.79	-189.94	174.30	98.96	61.43	-125.81	118.83	45.84	-16.37
Free Operating CF	-102.61	-62.74	-24.18	-64.16	46.06	-30.84	137.77	-184.96	189.25	103.10	61.43	-111.01	127.71	51.76	-10.55

Business Segment Analysis

FY End:

Mar 26

Insecticides (India) Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Technical and formation (100.0%)₹ 94.59 Cr

Revenue / Sales

Technical and formation (100.0%)₹ 2,140.01 Cr

Assets

Technical and formation (100.0%)₹ 2,000.18 Cr

Operating Income

Technical and formation (100.0%)₹ 203.23 Cr

Regional Segment Analysis

FY End:

Mar 26

Insecticides (India) Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

With in India (95.0%)₹ 2,028.95 CrOutside India (5.0%)₹ 107.67 Cr

Historical Segment Analysis

Track how Insecticides (India) Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2010 Mar 31	2011 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Technical and formation	-	-	-	-	-	-	-	29	48	67	87	49	37	95
Eliminations	0	-	0	0	0	0	0	-	-	-	-	-	-	-
Formulations	7	8	37	27	11	13	9	-	-	-	-	-	-	-
Technicals	1	-	10	18	20	3	2	-	-	-	-	-	-	-
unallocated	0	52	3	1	7	4	3	-	-	-	-	-	-	-

Frequently Asked Questions

What is the revenue of Insecticides (India) Ltd.?

The latest trailing twelve month revenue of Insecticides (India) Ltd. is ₹ 2,140.01 Cr, reflecting a 1-year growth of 7.00% and a 3-year CAGR of 5.91%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Insecticides (India) Ltd.?

The latest trailing twelve month net profit (PAT) of Insecticides (India) Ltd. is ₹ 139.41 Cr, with a 3-year earnings CAGR of 30.91%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Insecticides (India) Ltd.?

The trailing twelve month EBITDA of Insecticides (India) Ltd. is approximately ₹ 191.55 Cr (based on an operating margin of 8.95%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Insecticides (India) Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Insecticides (India) Ltd. is 47.91. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Insecticides (India) Ltd.?

The debt-to-equity ratio of Insecticides (India) Ltd. stands at 0.13. The interest coverage ratio is 11.35x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Insecticides (India) Ltd.?

The estimated book value per share of Insecticides (India) Ltd. is 426.34 (derived from a P/B ratio of 1.44 and market price of ₹ 615.25), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Insecticides (India) Ltd.?

The trailing twelve month operating cash flow of Insecticides (India) Ltd. is ₹ 84.04 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Insecticides (India) Ltd. report consolidated or standalone financials?

Insecticides (India) Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.